Weighted Cumulative Exposure of HbA1c and LDL-C and All-Cause Mortality in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study
INTRODUCTION: The long-term impact of glycemic and lipid control on prognosis in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) remains incompletely understood, as conventional metrics fail to capture the temporal accumulation of exposure. This study aimed to apply the weighted cumulative exposure (WCE) model to quantify the time-weighted cumulative effects of glycated hemoglobin (HbA1c) and low-density lipoprotein cholesterol (LDL-C) on all-cause mortality. METHODS: This retrospective cohort study used electronic health records from January 2000 to April 2025 from the Tianjin Health and Medical Big Data Platform. WCE models with one-knot constrained splines were fitted for HbA1c and LDL-C, with the optimal lag window selected by the Akaike and Bayesian information criteria (AIC/BIC). Multivariable Cox models were constructed with HbA1c-WCE and LDL-WCE as separate exposures, forcing glucose- and lipid-lowering medications into the models. Model fit of baseline, time-weighted mean, and WCE definitions was compared. RESULTS: A total of 7978 patients were included (median follow-up 5.04 years; 402 deaths). A uniform 60-month lag window was adopted. HbA1c weight peaked at approximately 17 months before death and then declined; LDL-C weight peaked at about 33 months and remained non-negative throughout. After adjustment, sustained HbA1c 8% versus 6.5% had a hazard ratio of 1.14 (1.04-1.27); sustained LDL-C 3.4 versus 1.8 mmol/l had a hazard ratio of 1.40 (1.10-1.74). The time-weighted mean yielded the lowest AIC for both markers. CONCLUSIONS: HbA1c's effect peaked early and declined, suggesting that recent values carry greater prognostic weight and supporting regular reassessment rather than reliance on a single baseline value, whereas LDL-C's effect emerged more slowly and persisted longer, suggesting a role for early initiation and sustained adherence.
Authors
- Chong Ma (ORCID: https://orcid.org/0009-0009-0447-9331)
- Yue Xi
- Guichun Tang (ORCID: https://orcid.org/0009-0001-0274-0155)
- Xiaolong Wang
- Minghui Hou
- Jian Yang
- Zheyi Dong
Institutions
- National Kidney Foundation (US)
- State Administration of Traditional Chinese Medicine of the People's Republic of China (CN)
- Chinese PLA General Hospital (CN)
- National Clinical Research (US)
- State Key Laboratory of Kidney Diseases (CN)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1007/s13300-026-01936-7
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science and Technology Major Project